Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings' Liabilities and Shareholders Equity was $21.14 million in Q2 2026, up 81.7% from $11.63 million a year earlier but down 10.3% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Reviva Pharmaceuticals Holdings came in at $15.92 million, up 2.7% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $15.5 million in FY2024 (-34.6%), $23.7 million in FY2023 (+25.2%) and $18.92 million in FY2022.
  • Quarterly Liabilities and Shareholders Equity has moved between $5.39 million (Q3 2023) and $33.89 million (Q3 2021) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity has increased for five straight quarters, with growth averaging 51.1% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q1 2022 (growth of 279.5%); the worst was Q3 2023 (a decline of 77.6%).
  • Per Business Quant data, RVPH's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $23.56 million (Q1 2026), $15.92 million (Q4 2025) and $14.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - 21.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.14 Mn
Mar 31, 2026 23.56 Mn
Dec 31, 2025 15.92 Mn
Sep 30, 2025 14.33 Mn
Jun 30, 2025 11.63 Mn
Mar 31, 2025 7.08 Mn
Dec 31, 2024 15.50 Mn
Sep 30, 2024 7.63 Mn
Jun 30, 2024 8.05 Mn
Mar 31, 2024 13.50 Mn
Dec 31, 2023 23.70 Mn
Sep 30, 2023 5.39 Mn
Jun 30, 2023 11.84 Mn
Mar 31, 2023 12.90 Mn
Dec 31, 2022 18.92 Mn
Sep 30, 2022 24.04 Mn
Jun 30, 2022 20.64 Mn
Mar 31, 2022 25.27 Mn
Dec 31, 2021 31.40 Mn
Sep 30, 2021 33.89 Mn
API Access

Reviva Pharmaceuticals Holdings Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RVPH&period=max&api_key=YOUR_API_KEY